VP22 fusion protein-based dominant negative mutant can inhibit hepatitis B virus replication

AIM: To investigate the inhibitory effect of VP22 fusion protein-based dominant negative (DN) mutant on Hepatitis Bvrus (HBV) replication. METHODS: Full-length or truncated fragment of VP22 was fused to C terminal of HBV core protein (HBc), and subcloned into pcDNA3.1 (-) vector, yielding eukaryotic...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:World J Gastroenterol
Auteurs principaux: Yi, Jun, Gong, Wei-Dong, Wang, Ling, Ling, Rui, Chen, Jiang-Hao, Yun, Jun
Format: Artigo
Langue:Inglês
Publié: Baishideng Publishing Group Inc 2005
Sujets:
Viral Hepatitis
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4355781/
https://ncbi.nlm.nih.gov/pubmed/16425411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v11.i41.6429
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires